Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | ACHE | P22303 | 4/20 | 0.47 |
| ▸ | APEX1 | P27695 | 3/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.39 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6544618 | 0.97 | APEX1 (0.50) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL12173199 | 0.81 | MEN1 (0.53) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL19929624 | 0.76 | MEN1 (0.41) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL12173197 | 0.73 | MEN1 (0.50) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL19929621 | 0.72 | MEN1 (0.38) | MEN1KMT2AACHEAPEX1NFKB1 | |
| Hydrochloric Acid SCHEMBL7205565 | 0.72 | APEX1 (0.48) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL2715248 | 0.71 | HTT (0.65) | KMT2ALMNADNM1 | |
| SCHEMBL17256642 | 0.71 | HTT (0.65) | KMT2ALMNADNM1 | |
| Hydrochloric Acid SCHEMBL6046691 | 0.71 | APEX1 (0.53) | MEN1KMT2AACHEAPEX1NFKB1 | |
| Iodide SCHEMBL22263021 | 0.69 | HTT (0.62) | KMT2ALMNADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1082223-B1 | IMAGING AND PRINTING METHODS USING CLAY-CONTAINING FLUID RECEIVING ELEMENT | KODAK POLYCHROME GRAPHICS CO (US) | 2004-01-07 | — | — | EP | claimed |
| US-10258046-B2 | Antimicrobial coatings comprising quaternary silanes | ALLIED BIOSCIENCE, INC. (US) | 2019-04-16 | — | — | US | disclosed |
| US-10238114-B2 | Methods of preparing reactive mixtures of silanes and triethanolamine and polymers therefrom | SRFC BIO, INC. | 2019-03-26 | — | — | US | disclosed |
| US-10194664-B2 | Methods of preparing self-decontaminating surfaces using reactive silanes, triethanolamine and titanium anatase sol | ALLIED BIOSCIENCE, INC. (US) | 2019-02-05 | — | — | US | disclosed |
| US-9963596-B2 | Synergistic combinations of choline and reactive silanes in antimicrobial coatings | ALLIED BIOSCIENCE, INC. (US) | 2018-05-08 | — | — | US | disclosed |
| US-9918475-B2 | Anti-microbial coating and method to form same | ALLIED BIOSCIENCE, INC. (US) | 2018-03-20 | — | — | US | disclosed |
| US-20170166755-A1 | SYNERGISTIC COMBINATIONS OF CHOLINE AND REACTIVE SILANES IN ANTIMICROBIAL COATINGS | ALLIED BIOSCIENCE, INC. (US) | 2017-06-15 | — | — | US | disclosed |
| US-20170152401-A1 | METHODS OF PREPARING REACTIVE MIXTURES OF SILANES AND TRIETHANOLAMINE AND POLYMERS THEREFROM | ALLIED BIOSCIENCE, INC. (US) | 2017-06-01 | — | — | US | disclosed |
| US-20170150723-A1 | METHODS OF PREPARING SELF-DECONTAMINATING SURFACES USING REACTIVE SILANES, TRIETHANOLAMINE AND TITANIUM ANATASE SOL | ALLIED BIOSCIENCE, INC. (US) | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10194664-B2 | Methods of preparing self-decontaminating surfaces using reactive silanes, triethanolamine and titanium anatase sol | PHOSPHO1, SAT1, SEPTIN8 | MEN1 2337/4885KMT2A 423/4885ACHE 917/4885 |
| US-10238114-B2 | Methods of preparing reactive mixtures of silanes and triethanolamine and polymers therefrom | PHOSPHO1, SGMS1, SGMS2 | MEN1 2352/4885KMT2A 355/4885ACHE 1002/4885 |
| US-20170152401-A1 | METHODS OF PREPARING REACTIVE MIXTURES OF SILANES AND TRIETHANOLAMINE AND POLYMERS THEREFROM | PHOSPHO1, SGMS1, SGMS2 | MEN1 2352/4885KMT2A 355/4885ACHE 1002/4885 |
| US-20170150723-A1 | METHODS OF PREPARING SELF-DECONTAMINATING SURFACES USING REACTIVE SILANES, TRIETHANOLAMINE AND TITANIUM ANATASE SOL | PHOSPHO1, SAT1, SEPTIN8 | MEN1 2337/4885KMT2A 423/4885ACHE 917/4885 |
| US-10258046-B2 | Antimicrobial coatings comprising quaternary silanes | TET3, TET2, TET1 | MEN1 3151/4885KMT2A 930/4885ACHE 973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.